E. Castigli et al., CD40-DEFICIENT MICE GENERATED BY RECOMBINATION-ACTIVATING GENE-2-DEFICIENT BLASTOCYST COMPLEMENTATION, Proceedings of the National Academy of Sciences of the United Statesof America, 91(25), 1994, pp. 12135-12139
To study the role of the B-cell antigen CD40 in immune responses, mous
e embryonic stem (ES) cells in which both copies of the gene encoding
CD40 had been disrupted by homologous recombination were injected in R
AG-2 (recombination-activating gene-2)-deficient blastocysts to genera
te chimeras in which all mature lymphocytes are derived from the CD40-
deficient ES cells. T- and B-cell number and phenotype were normal in
the CD40(-/-) chimeras. However, B cells failed to proliferate and und
ergo isotype switching in vitro in response to soluble CD40 ligand (sC
D40L) with interleukin 4 (IL-4) but responded normally to lipopolysacc
haride (LPS) with IL-4. CD40(-/-) chimeras completely failed to mount
an antigen-specific antibody response or to develop germinal centers f
ollowing immunization with the T cell-dependent (TD) antigen keyhole l
impet hemocyanin. In contrast, CD40(-/-) mutant mice responded normall
y to the T cell-independent (TI) antigens 2,4,6-trinitrophenyl (TNP)-L
PS and TNP-Ficoll. The most noticeable alteration in the serum immunog
lobulin levels of young (6-8 weeks old) CD40(-/-) animals was absence
of IgE and severe decrease of IgG1 and IgG2a. These results confirm th
e essential role of CD40-CD40L interactions in the antibody response t
o TD antigens and in isotype switching.